Impact of Teeth Extraction on Inflammation Marker's Levels in Patients Who Undergoing Cardiac Surgery

Sponsor
University of Trieste (Other)
Overall Status
Recruiting
CT.gov ID
NCT04626011
Collaborator
(none)
38
1
2
24
1.6

Study Details

Study Description

Brief Summary

The aim of this study is to examine effects of dental treatments, surgical (extractions) and non-surgical procedures (non-surgical periodontal therapy), on serum levels for PCR, WBCs and PCT in patients needing a dental remediation before undergoing cardiac surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Tooth extractions
N/A

Detailed Description

Introduction. The association between periodontal disease and cardiovascular disease is already established. Chronic inflammation of periodontal tissues primes the release of inflammatory markers such as: PCR, IL-1, IL-6 and TNF alpha and also,an even more accurate marker, procalcitonin (PCT).

Aim. The aim of this study is to examine effects of dental treatments, surgical (extractions) and non-surgical procedures (non-surgical periodontal therapy), on serum levels for PCR, WBCs and PCT in patients needing a dental remediation before undergoing cardiac surgery.

Materials and methods. This study is designed to be a clinical trial. 38 patients will be recruited at the Cardiological Center at Cattinara Hospital (ASUITS) and they will be treated in Maxillofacial Surgery and Stomatology Clinic at Major Hospital (ASUITS). Inclusion criteria: adult age, consciousness and willingness to sign an informed consent, anamnestic history of cardiovascular disease, also needing cardiac surgery and dental reclamation, stage 3-4 grade B-C for periodontal disease diagnosed . Exclusion criteria: pregnancy, genetic dysmorphisms which have an impact on the periodontal health status (Down Syndrome), diabetes or immune system disorders, HIV, hardly smoking, blood disorders, urgent cardiac surgery or a too large dental remediation to be performed in just 2 dental sessions, patients who underwent dental treatments in the previous 2 months. At baseline, all patients will undergo blood tests (blood cell count, PCR, PCT and WBC count), periodontal analysis (FMPS, FMBS and PISA index recording), orthopantomography and anamnestic record. Afterwards they will be assigned, randomly following a 1:1 ratio to Gruppo1 (fullmouth disinfection therapy + extractions all in one session) or Gruppo2 (fullmouth disinfection therapy and after one week extractions). All patients will undergo blood chemistry tests (CPR, PCT, WBC) after 1, 7 and 14 days.

Statistical analysis. All data will be presented as a mean and standard deviation, unless another method will be specified. After the control of parametric data distribution we will proceed with the statistical analysis of the different biomarkers recorded over time by ANOVA for repeated measurements and by t-test between the different groups in the same time intervals.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
38 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
Impact of Total Teeth Extraction on Inflammation Marker's Levels in Patients Who Undergoing Cardiac Surgery: Clinical Trial.
Actual Study Start Date :
Oct 5, 2020
Anticipated Primary Completion Date :
Oct 5, 2022
Anticipated Study Completion Date :
Oct 5, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group One

Participants receiving full mouth disinfection and extractions in one stage.

Procedure: Tooth extractions
After blood collection tests, Periodontal analysis, Orthopantomography and Anamnestic record each group will receive a full mouth disinfection and needed extractions.
Other Names:
  • Inflammation markers evaluation
  • Active Comparator: Group Two

    Participants receiving full mouth disinfection at stage one and extractions at stage two after 7 days.

    Procedure: Tooth extractions
    After blood collection tests, Periodontal analysis, Orthopantomography and Anamnestic record each group will receive a full mouth disinfection and needed extractions.
    Other Names:
  • Inflammation markers evaluation
  • Outcome Measures

    Primary Outcome Measures

    1. Dental protocol to be followed in patients undergoing cardiac surgery by measuring changes in serum inflammatory markers. [Changes from baseline of serum inflammatory markers after 1 day, 7 days and 14 days.]

      To find out which dental procedures protocol to be used to reduce serum inflammation markers as TNF alfa, IL 6, CPR, WBC and PCT values in patient undergoing cardiac surgery using a sample of 38 patients.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • adult age, consciousness and willingness to sign an informed consent, anamnestic history of cardiovascular disease, also needing cardiac surgery and dental reclamation, stage 3-4 grade B-C for periodontal disease diagnosed
    Exclusion Criteria:
    • pregnancy, genetic dysmorphisms which have an impact on the periodontal health status (Down Syndrome), diabetes or immune system disorders, HIV, hardly smoking, blood disorders, urgent cardiac surgery or a too large dental remediation to be performed in just 2 dental sessions, patients who underwent dental treatments in the previous 2 months

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Medical Sciences, University of Trieste Trieste Italy, Trieste Italy 34127

    Sponsors and Collaborators

    • University of Trieste

    Investigators

    • Principal Investigator: Lorenzo Bevilacqua, DDS, Clinica Stomatologia, Piazza dell'Ospitale 1, Ospedale Maggiore 34125 Trieste Italia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Bevilacqua Lorenzo, Clinical professor, DDS, MsC, University of Trieste
    ClinicalTrials.gov Identifier:
    NCT04626011
    Other Study ID Numbers:
    • BLorenzo
    First Posted:
    Nov 12, 2020
    Last Update Posted:
    May 3, 2021
    Last Verified:
    Apr 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Bevilacqua Lorenzo, Clinical professor, DDS, MsC, University of Trieste
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 3, 2021